Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMY DERICKS LOBER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1104070135
CMS profile
10440771
Location
NEPTUNE, NJ

General Payments · PY2021–2024

$4,473.47

  • Reported across 319 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$815.22

58 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $815.22 58

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $184.24 18
Novo Nordisk AS $174.03 11
Acerta Pharma LLC $150.71 10
Corcept Therapeutics $87.47 6
Amgen Inc. $61.22 4
Antares Pharma, Inc. $40.36 2
PFIZER INC. $32.23 2
Bayer HealthCare Pharmaceuticals Inc. $23.31 1
Lilly USA, LLC $16.41 1
GlaxoSmithKline, LLC. $15.79 1
Currax Pharmaceuticals LLC $15.29 1
TOLMAR, INC. $14.16 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,623.09 121
PY2022 $1,300.03 89
PY2023 $735.13 51
PY2024 $815.22 58

Payment records · PY2024 (58)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.79 01/30/2024 Food and Beverage Undisputed 01/23/2026 1107548636 CMS
ABBVIE INC. $13.43 02/02/2024 Food and Beverage Undisputed 01/23/2026 1107548638 CMS
ABBVIE INC. $13.69 02/20/2024 Food and Beverage Undisputed 01/23/2026 1107548640 CMS
ABBVIE INC. $16.77 02/26/2024 Food and Beverage Undisputed 01/23/2026 1107548642 CMS
ABBVIE INC. $14.80 03/06/2024 Food and Beverage Undisputed 01/23/2026 1107548644 CMS
ABBVIE INC. $13.86 03/11/2024 Food and Beverage Undisputed 01/23/2026 1107548646 CMS
ABBVIE INC. $13.76 03/12/2024 Food and Beverage Undisputed 01/23/2026 1107548648 CMS
ABBVIE INC. $12.86 05/06/2024 Food and Beverage Undisputed 01/23/2026 1107548650 CMS
ABBVIE INC. $12.66 06/05/2024 Food and Beverage Undisputed 01/23/2026 1107548652 CMS
ABBVIE INC. $8.38 06/10/2024 Food and Beverage Undisputed 01/23/2026 1107548654 CMS
ABBVIE INC. $8.17 07/18/2024 Food and Beverage Undisputed 01/23/2026 1107548656 CMS
ABBVIE INC. $5.85 08/20/2024 Food and Beverage Undisputed 01/23/2026 1107548658 CMS
ABBVIE INC. $4.72 09/11/2024 Food and Beverage Undisputed 01/23/2026 1107548660 CMS
ABBVIE INC. $3.41 10/14/2024 Food and Beverage Undisputed 01/23/2026 1107548662 CMS
ABBVIE INC. $4.32 11/11/2024 Food and Beverage Undisputed 01/23/2026 1107548664 CMS
ABBVIE INC. $6.93 11/25/2024 Food and Beverage Undisputed 01/23/2026 1107548666 CMS
ABBVIE INC. $8.81 12/10/2024 Food and Beverage Undisputed 01/23/2026 1107548668 CMS
ABBVIE INC. $5.03 12/17/2024 Food and Beverage Undisputed 01/23/2026 1107548670 CMS
Amgen Inc. $13.42 02/05/2024 Food and Beverage Undisputed 01/23/2026 1117612995 CMS
Amgen Inc. $16.11 05/28/2024 Food and Beverage Undisputed 01/23/2026 1115878921 CMS
Amgen Inc. $15.64 06/25/2024 Food and Beverage Undisputed 01/23/2026 1117612997 CMS
Amgen Inc. $16.05 12/03/2024 Food and Beverage Undisputed 01/23/2026 1117612999 CMS
Antares Pharma, Inc. $20.78 01/22/2024 Food and Beverage Undisputed 01/23/2026 1146513256 CMS
Antares Pharma, Inc. $19.58 05/13/2024 Food and Beverage Undisputed 01/23/2026 1146513260 CMS
AstraZeneca Pharmaceuticals LP $15.56 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105641998 CMS
AstraZeneca Pharmaceuticals LP $16.67 02/19/2024 Food and Beverage Undisputed 01/23/2026 1105732997 CMS
AstraZeneca Pharmaceuticals LP $2.85 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105852024 CMS
AstraZeneca Pharmaceuticals LP $16.78 03/19/2024 Food and Beverage Undisputed 01/23/2026 1104417879 CMS
AstraZeneca Pharmaceuticals LP $15.23 04/24/2024 Food and Beverage Undisputed 01/23/2026 1105830303 CMS
AstraZeneca Pharmaceuticals LP $15.96 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105589938 CMS
AstraZeneca Pharmaceuticals LP $16.45 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104580586 CMS
AstraZeneca Pharmaceuticals LP $17.71 05/30/2024 Food and Beverage Undisputed 01/23/2026 1105761380 CMS
AstraZeneca Pharmaceuticals LP $17.36 09/30/2024 Food and Beverage Undisputed 01/23/2026 1104615304 CMS
AstraZeneca Pharmaceuticals LP $16.14 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105639608 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.31 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086280962 CMS
Corcept Therapeutics $13.32 02/12/2024 Food and Beverage Undisputed 01/23/2026 1117776128 CMS
Corcept Therapeutics $13.98 05/14/2024 Food and Beverage Undisputed 01/23/2026 1117776158 CMS
Corcept Therapeutics $15.09 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117776204 CMS
Corcept Therapeutics $14.01 10/29/2024 Food and Beverage Undisputed 01/23/2026 1117776222 CMS
Corcept Therapeutics $16.28 11/26/2024 Food and Beverage Undisputed 01/23/2026 1117776238 CMS
Corcept Therapeutics $14.79 12/10/2024 Food and Beverage Undisputed 01/23/2026 1117776250 CMS
Currax Pharmaceuticals LLC $15.29 01/09/2024 Food and Beverage Undisputed 01/23/2026 1089517627 CMS
GlaxoSmithKline, LLC. $15.79 04/02/2024 Food and Beverage Undisputed 01/23/2026 1116333567 CMS
Lilly USA, LLC $16.41 04/30/2024 Food and Beverage Undisputed 01/23/2026 1135521619 CMS
Novo Nordisk Inc $16.79 01/18/2024 Food and Beverage Undisputed 01/23/2026 1100260553 CMS
Novo Nordisk Inc $16.45 02/16/2024 Food and Beverage Undisputed 01/23/2026 1100276488 CMS
Novo Nordisk Inc $15.15 04/18/2024 Food and Beverage Undisputed 01/23/2026 1100337453 CMS
Novo Nordisk Inc $15.37 05/15/2024 Food and Beverage Undisputed 01/23/2026 1100502939 CMS
Novo Nordisk Inc $17.21 06/12/2024 Food and Beverage Undisputed 01/23/2026 1100505319 CMS
Novo Nordisk Inc $15.93 06/17/2024 Food and Beverage Undisputed 01/23/2026 1100648071 CMS
Novo Nordisk Inc $15.37 07/16/2024 Food and Beverage Undisputed 01/23/2026 1100432723 CMS
Novo Nordisk Inc $11.05 08/14/2024 Food and Beverage Undisputed 01/23/2026 1100264274 CMS
Novo Nordisk Inc $15.80 10/03/2024 Food and Beverage Undisputed 01/23/2026 1100648997 CMS
Novo Nordisk Inc $22.02 11/04/2024 Food and Beverage Undisputed 01/23/2026 1100427733 CMS
Novo Nordisk Inc $12.89 11/13/2024 Food and Beverage Undisputed 01/23/2026 1100277866 CMS
PFIZER INC. $15.85 03/14/2024 Food and Beverage Undisputed 01/23/2026 1131166413 CMS
PFIZER INC. $16.38 06/25/2024 Food and Beverage Undisputed 01/23/2026 1132012392 CMS
Tolmar, Inc. $14.16 05/21/2024 Food and Beverage Undisputed 01/23/2026 1138717414 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.